These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 26520047)

  • 1. HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?
    Takes RP; Wierzbicka M; D'Souza G; Jackowska J; Silver CE; Rodrigo JP; Dikkers FG; Olsen KD; Rinaldo A; Brakenhoff RH; Ferlito A
    Oral Oncol; 2015 Dec; 51(12):1057-60. PubMed ID: 26520047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The disease burden of human papillomavirus in men is substantial and can potentially be prevented].
    Kiellberg Larsen H; Kofoed K; Sand C
    Ugeskr Laeger; 2013 Feb; 175(6):349-53. PubMed ID: 23402241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concerned about HPV-related cancer rise, researchers advocate boosting HPV vaccination rates.
    Azvolinsky A
    J Natl Cancer Inst; 2013 Sep; 105(18):1335-6. PubMed ID: 23990671
    [No Abstract]   [Full Text] [Related]  

  • 4. The HPV infection in males: an update.
    Giraldi G; De Luca d'Alessandro E
    Ann Ig; 2012; 24(6):497-506. PubMed ID: 23234187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
    Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
    Medeiros R; Vaz S; Rebelo T; Figueiredo-Dias M
    Acta Med Port; 2020 Mar; 33(3):198-201. PubMed ID: 32130098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
    Goldstone SE; Vuocolo S
    Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
    Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL
    BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HPV vaccination].
    Stronski Huwiler S; Spaar A
    Ther Umsch; 2016; 73(5):241-6. PubMed ID: 27268446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic human papillomavirus vaccines: past, present and future.
    Anderson LA
    Pathology; 2012 Jan; 44(1):1-6. PubMed ID: 22157686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
    Guo T; Eisele DW; Fakhry C
    Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral HPV: the need for patient education.
    Merchant VA
    J Mich Dent Assoc; 2012 Mar; 94(3):16, 83. PubMed ID: 22662379
    [No Abstract]   [Full Text] [Related]  

  • 13. HPV vaccination in head and neck HPV-related pathologies.
    Wierzbicka M; Józefiak A; Jackowska J; Szydłowski J; Goździcka-Józefiak A
    Otolaryngol Pol; 2014; 68(4):157-73. PubMed ID: 24981297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
    Vaccine; 2013 Dec; 31 Suppl 5():F1-31. PubMed ID: 24331745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human Papillomavirus infection and vaccination: knowledge and attitudes of Italian general practitioners].
    Signorelli C; Odone A; Pezzetti F; Spagnoli F; Visciarelli S; Ferrari A; Camia P; Latini C; Ciorba V; Agodi A; Barchitta M; Scotti S; Misericordia P; Pasquarella C
    Epidemiol Prev; 2014; 38(6 Suppl 2):88-92. PubMed ID: 25759351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.
    Pitisuttithum P; Velicer C; Luxembourg A
    Expert Rev Vaccines; 2015; 14(11):1405-19. PubMed ID: 26366475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection.
    Timbang MR; Sim MW; Bewley AF; Farwell DG; Mantravadi A; Moore MG
    Hum Vaccin Immunother; 2019; 15(7-8):1920-1928. PubMed ID: 31050595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV: diagnosis, prevention, and treatment.
    Hathaway JK
    Clin Obstet Gynecol; 2012 Sep; 55(3):671-80. PubMed ID: 22828099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the monovalent to the nine-valent HPV vaccine.
    Pils S; Joura EA
    Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
    Vaccine; 2013 Nov; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.